|
Transgenomic Announces Closing of Public Offering of Common Stock
PharmiWeb.com (press release) Transgenomic Inc. (NASDAQ: TBIO) today announced the closing of its underwritten public offering of 3573899 shares of the company’s common stock and corresponding warrants to purchase 714780 shares of the company’s common stock. The common … |
